ID   ELOV4_HUMAN             Reviewed;         314 AA.
AC   Q9GZR5; B2R6B5; Q5TCS2; Q86YJ1; Q9H139;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-MAY-2017, entry version 145.
DE   RecName: Full=Elongation of very long chain fatty acids protein 4 {ECO:0000255|HAMAP-Rule:MF_03204, ECO:0000305};
DE            EC=2.3.1.199 {ECO:0000255|HAMAP-Rule:MF_03204, ECO:0000269|PubMed:20937905};
DE   AltName: Full=3-keto acyl-CoA synthase ELOVL4 {ECO:0000255|HAMAP-Rule:MF_03204};
DE   AltName: Full=ELOVL fatty acid elongase 4 {ECO:0000255|HAMAP-Rule:MF_03204};
DE            Short=ELOVL FA elongase 4 {ECO:0000255|HAMAP-Rule:MF_03204};
DE   AltName: Full=Very long chain 3-ketoacyl-CoA synthase 4 {ECO:0000255|HAMAP-Rule:MF_03204};
DE   AltName: Full=Very long chain 3-oxoacyl-CoA synthase 4 {ECO:0000255|HAMAP-Rule:MF_03204};
GN   Name=ELOVL4 {ECO:0000255|HAMAP-Rule:MF_03204};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], VARIANT VAL-299, AND
RP   DISEASE.
RC   TISSUE=Retina;
RX   PubMed=11138005; DOI=10.1038/83817;
RA   Zhang K., Kniazeva M., Han M., Li W., Yu Z., Yang Z., Li Y.,
RA   Metzker M.L., Allikmets R., Zack D.J., Kakuk L.E., Lagali P.S.,
RA   Wong P.W., McDonald I.M., Sieving P.A., Figueroa D.J., Austin C.P.,
RA   Gould R.J., Ayyagari R., Petrukhin K.;
RT   "A 5-bp deletion in ELOVL4 is associated with two related forms of
RT   autosomal dominant macular dystrophy.";
RL   Nat. Genet. 27:89-93(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INVOLVEMENT IN STGD3.
RX   PubMed=11581213;
RA   Edwards A.O., Donoso L.A., Ritter R. III;
RT   "A novel gene for autosomal dominant Stargardt-like macular dystrophy
RT   with homology to the SUR4 protein family.";
RL   Invest. Ophthalmol. Vis. Sci. 42:2652-2663(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SUBCELLULAR LOCATION, OLIGOMERIZATION, AND GLYCOSYLATION AT ASN-20.
RX   PubMed=16036915; DOI=10.1074/jbc.M503411200;
RA   Grayson C., Molday R.S.;
RT   "Dominant negative mechanism underlies autosomal dominant Stargardt-
RT   like macular dystrophy linked to mutations in ELOVL4.";
RL   J. Biol. Chem. 280:32521-32530(2005).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=20937905; DOI=10.1073/pnas.1005572107;
RA   Ohno Y., Suto S., Yamanaka M., Mizutani Y., Mitsutake S., Igarashi Y.,
RA   Sassa T., Kihara A.;
RT   "ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid
RT   synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:18439-18444(2010).
RN   [9]
RP   PROBABLE ROLE IN BRAIN AND SKIN DEVELOPMENT, AND INVOLVEMENT IN ISQMR.
RX   PubMed=22100072; DOI=10.1016/j.ajhg.2011.10.011;
RA   Aldahmesh M.A., Mohamed J.Y., Alkuraya H.S., Verma I.C., Puri R.D.,
RA   Alaiya A.A., Rizzo W.B., Alkuraya F.S.;
RT   "Recessive mutations in ELOVL4 cause ichthyosis, intellectual
RT   disability, and spastic quadriplegia.";
RL   Am. J. Hum. Genet. 89:745-750(2011).
RN   [10]
RP   VARIANTS THR-267 AND VAL-299.
RX   PubMed=12592226;
RA   Rivolta C., Ayyagari R., Sieving P.A., Berson E.L., Dryja T.P.;
RT   "Evaluation of the ELOVL4 gene in patients with autosomal recessive
RT   retinitis pigmentosa and Leber congenital amaurosis.";
RL   Mol. Vis. 9:49-51(2003).
RN   [11]
RP   INVOLVEMENT IN SCA34, AND VARIANT SCA34 PHE-168.
RX   PubMed=24566826; DOI=10.1001/jamaneurol.2013.6337;
RA   Cadieux-Dion M., Turcotte-Gauthier M., Noreau A., Martin C.,
RA   Meloche C., Gravel M., Drouin C.A., Rouleau G.A., Nguyen D.K.,
RA   Cossette P.;
RT   "Expanding the clinical phenotype associated with ELOVL4 mutation:
RT   study of a large French-Canadian family with autosomal dominant
RT   spinocerebellar ataxia and erythrokeratodermia.";
RL   JAMA Neurol. 71:470-475(2014).
CC   -!- FUNCTION: Catalyzes the first and rate-limiting reaction of the
CC       four that constitute the long-chain fatty acids elongation cycle.
CC       This endoplasmic reticulum-bound enzymatic process, allows the
CC       addition of 2 carbons to the chain of long- and very long-chain
CC       fatty acids/VLCFAs per cycle. Condensing enzyme that specifically
CC       elongates C24:0 and C26:0 acyl-CoAs. May participate in the
CC       production of saturated and monounsaturated VLCFAs of different
CC       chain lengths that are involved in multiple biological processes
CC       as precursors of membrane lipids and lipid mediators. May play a
CC       critical role in early brain and skin development.
CC       {ECO:0000255|HAMAP-Rule:MF_03204, ECO:0000269|PubMed:20937905}.
CC   -!- CATALYTIC ACTIVITY: A very-long-chain acyl-CoA + malonyl-CoA = CoA
CC       + a very-long-chain 3-oxoacyl-CoA + CO(2). {ECO:0000255|HAMAP-
CC       Rule:MF_03204, ECO:0000269|PubMed:20937905}.
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC       {ECO:0000255|HAMAP-Rule:MF_03204, ECO:0000269|PubMed:20937905}.
CC   -!- SUBUNIT: Oligomer. {ECO:0000255|HAMAP-Rule:MF_03204,
CC       ECO:0000269|PubMed:16036915}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000255|HAMAP-Rule:MF_03204, ECO:0000269|PubMed:16036915,
CC       ECO:0000269|PubMed:20937905}; Multi-pass membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_03204}.
CC   -!- TISSUE SPECIFICITY: Expressed in the retina and at much lower
CC       level in the brain. Ubiquitous, highest expression in thymus,
CC       followed by testis, small intestine, ovary, and prostate. Little
CC       or no expression in heart, lung, liver, or leukocates.
CC       {ECO:0000269|PubMed:20937905}.
CC   -!- DOMAIN: The C-terminal di-lysine motif may confer endoplasmic
CC       reticulum localization. {ECO:0000255|HAMAP-Rule:MF_03204}.
CC   -!- DISEASE: Stargardt disease 3 (STGD3) [MIM:600110]: A common
CC       hereditary macular degeneration. It is characterized by decreased
CC       central vision, atrophy of the macula and underlying retinal
CC       pigment epithelium, and frequent presence of prominent flecks in
CC       the posterior pole of the retina. {ECO:0000269|PubMed:11138005,
CC       ECO:0000269|PubMed:11581213}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Ichthyosis, spastic quadriplegia, and mental retardation
CC       (ISQMR) [MIM:614457]: A severe autosomal recessive disorder
CC       characterized by ichthyosis apparent from birth, profound
CC       psychomotor retardation with essentially no development, spastic
CC       quadriplegia, and seizures. {ECO:0000269|PubMed:22100072}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Spinocerebellar ataxia 34 (SCA34) [MIM:133190]: A form of
CC       spinocerebellar ataxia, a clinically and genetically heterogeneous
CC       group of cerebellar disorders. Patients show progressive
CC       incoordination of gait and often poor coordination of hands,
CC       speech and eye movements, due to degeneration of the cerebellum
CC       with variable involvement of the brainstem and spinal cord. SCA34
CC       is an autosomal dominant form characterized by the association of
CC       progressive cerebellar ataxia with erythrokeratodermia variabilis.
CC       {ECO:0000269|PubMed:24566826}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ELO family. ELOVL4 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03204}.
CC   -!- WEB RESOURCE: Name=Mutations of the ELOVL4 gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/elovlmut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF279654; AAG47669.1; -; Genomic_DNA.
DR   EMBL; AF279649; AAG47669.1; JOINED; Genomic_DNA.
DR   EMBL; AF279650; AAG47669.1; JOINED; Genomic_DNA.
DR   EMBL; AF279651; AAG47669.1; JOINED; Genomic_DNA.
DR   EMBL; AF279652; AAG47669.1; JOINED; Genomic_DNA.
DR   EMBL; AF279653; AAG47669.1; JOINED; Genomic_DNA.
DR   EMBL; AF277094; AAG47668.1; -; mRNA.
DR   EMBL; AY037298; AAK68639.1; -; mRNA.
DR   EMBL; AK055277; BAB70895.1; -; mRNA.
DR   EMBL; AK312511; BAG35412.1; -; mRNA.
DR   EMBL; AL133475; CAI20320.1; -; Genomic_DNA.
DR   EMBL; AL132875; CAI20320.1; JOINED; Genomic_DNA.
DR   EMBL; AL132875; CAI23374.1; -; Genomic_DNA.
DR   EMBL; AL133475; CAI23374.1; JOINED; Genomic_DNA.
DR   EMBL; CH471051; EAW48701.1; -; Genomic_DNA.
DR   EMBL; BC038506; AAH38506.1; -; mRNA.
DR   CCDS; CCDS4992.1; -.
DR   RefSeq; NP_073563.1; NM_022726.3.
DR   UniGene; Hs.101915; -.
DR   ProteinModelPortal; Q9GZR5; -.
DR   SMR; Q9GZR5; -.
DR   BioGrid; 112661; 6.
DR   STRING; 9606.ENSP00000358831; -.
DR   DrugBank; DB00132; Alpha-Linolenic Acid.
DR   SwissLipids; SLP:000000255; -.
DR   iPTMnet; Q9GZR5; -.
DR   PhosphoSitePlus; Q9GZR5; -.
DR   SwissPalm; Q9GZR5; -.
DR   BioMuta; ELOVL4; -.
DR   DMDM; 20137966; -.
DR   EPD; Q9GZR5; -.
DR   PaxDb; Q9GZR5; -.
DR   PeptideAtlas; Q9GZR5; -.
DR   PRIDE; Q9GZR5; -.
DR   DNASU; 6785; -.
DR   Ensembl; ENST00000369816; ENSP00000358831; ENSG00000118402.
DR   GeneID; 6785; -.
DR   KEGG; hsa:6785; -.
DR   UCSC; uc003pja.5; human.
DR   CTD; 6785; -.
DR   DisGeNET; 6785; -.
DR   GeneCards; ELOVL4; -.
DR   HGNC; HGNC:14415; ELOVL4.
DR   MalaCards; ELOVL4; -.
DR   MIM; 133190; phenotype.
DR   MIM; 600110; phenotype.
DR   MIM; 605512; gene.
DR   MIM; 614457; phenotype.
DR   neXtProt; NX_Q9GZR5; -.
DR   OpenTargets; ENSG00000118402; -.
DR   Orphanet; 352333; Congenital ichthyosis - intellectual disability - spastic quadriplegia.
DR   Orphanet; 1955; Spinocerebellar ataxia type 34.
DR   Orphanet; 827; Stargardt disease.
DR   PharmGKB; PA27763; -.
DR   eggNOG; KOG3071; Eukaryota.
DR   eggNOG; ENOG410XRWT; LUCA.
DR   GeneTree; ENSGT00760000119122; -.
DR   HOGENOM; HOG000038120; -.
DR   HOVERGEN; HBG051468; -.
DR   InParanoid; Q9GZR5; -.
DR   KO; K10249; -.
DR   OMA; FYVRTYK; -.
DR   OrthoDB; EOG091G0N2V; -.
DR   PhylomeDB; Q9GZR5; -.
DR   TreeFam; TF323454; -.
DR   BioCyc; MetaCyc:ENSG00000118402-MONOMER; -.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   UniPathway; UPA00094; -.
DR   GeneWiki; ELOVL4; -.
DR   GenomeRNAi; 6785; -.
DR   PRO; PR:Q9GZR5; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000118402; -.
DR   CleanEx; HS_ELOVL4; -.
DR   Genevisible; Q9GZR5; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0102336; F:3-oxo-arachidoyl-CoA synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102337; F:3-oxo-cerotoyl-CoA synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102338; F:3-oxo-lignoceronyl-CoA synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009922; F:fatty acid elongase activity; IEA:InterPro.
DR   GO; GO:0008020; F:G-protein coupled photoreceptor activity; NAS:UniProtKB.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0019367; P:fatty acid elongation, saturated fatty acid; IDA:UniProtKB.
DR   GO; GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB.
DR   HAMAP; MF_03204; VLCF_elongase_4; 1.
DR   InterPro; IPR030457; ELO_CS.
DR   InterPro; IPR002076; ELO_fam.
DR   InterPro; IPR033678; ELOVL4.
DR   PANTHER; PTHR11157; PTHR11157; 1.
DR   Pfam; PF01151; ELO; 1.
DR   PROSITE; PS01188; ELO; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; Endoplasmic reticulum;
KW   Fatty acid biosynthesis; Fatty acid metabolism; Glycoprotein;
KW   Ichthyosis; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Mental retardation; Neurodegeneration; Polymorphism;
KW   Reference proteome; Spinocerebellar ataxia; Stargardt disease;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    314       Elongation of very long chain fatty acids
FT                                protein 4.
FT                                /FTId=PRO_0000207542.
FT   TRANSMEM     42     62       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03204}.
FT   TRANSMEM     78     98       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03204}.
FT   TRANSMEM    127    147       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03204}.
FT   TRANSMEM    165    185       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03204}.
FT   TRANSMEM    188    208       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03204}.
FT   TRANSMEM    217    237       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03204}.
FT   TRANSMEM    247    267       Helical. {ECO:0000255|HAMAP-
FT                                Rule:MF_03204}.
FT   MOTIF       310    314       Di-lysine motif. {ECO:0000255|HAMAP-
FT                                Rule:MF_03204}.
FT   CARBOHYD     20     20       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|HAMAP-Rule:MF_03204,
FT                                ECO:0000269|PubMed:16036915}.
FT   VARIANT     168    168       L -> F (in SCA34; dbSNP:rs587777598).
FT                                {ECO:0000269|PubMed:24566826}.
FT                                /FTId=VAR_072565.
FT   VARIANT     267    267       I -> T (in dbSNP:rs148594713).
FT                                {ECO:0000269|PubMed:12592226}.
FT                                /FTId=VAR_017043.
FT   VARIANT     299    299       M -> V (in dbSNP:rs3812153).
FT                                {ECO:0000269|PubMed:11138005,
FT                                ECO:0000269|PubMed:12592226}.
FT                                /FTId=VAR_012492.
FT   CONFLICT     44     44       Q -> R (in Ref. 6; AAH38506).
FT                                {ECO:0000305}.
SQ   SEQUENCE   314 AA;  36829 MW;  B2EBCE54D868E96E CRC64;
     MGLLDSEPGS VLNVVSTALN DTVEFYRWTW SIADKRVENW PLMQSPWPTL SISTLYLLFV
     WLGPKWMKDR EPFQMRLVLI IYNFGMVLLN LFIFRELFMG SYNAGYSYIC QSVDYSNNVH
     EVRIAAALWW YFVSKGVEYL DTVFFILRKK NNQVSFLHVY HHCTMFTLWW IGIKWVAGGQ
     AFFGAQLNSF IHVIMYSYYG LTAFGPWIQK YLWWKRYLTM LQLIQFHVTI GHTALSLYTD
     CPFPKWMHWA LIAYAISFIF LFLNFYIRTY KEPKKPKAGK TAMNGISANG VSKSEKQLMI
     ENGKKQKNGK AKGD
//
